mbiomics Appoints Seasoned Microbiome Expert Christopher Weidenmaier as Chief Scientific Officer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Fecal transplant not over yet for C difficile despite boom in live microbiota therapies healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Qiagen (NYSE:QGEN – Get Free Report) and Finch Therapeutics Group (NASDAQ:FNCH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, risk and institutional ownership. Earnings & Valuation This table compares Qiagen and […]
Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Free Report) saw a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 21,400 shares, an increase of 57.4% from the July 31st total of 13,600 shares. Currently, 3.8% of the shares of the company are short sold. […]
Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Free Report) traded down 1.5% on Tuesday . The company traded as low as $6.11 and last traded at $6.45. 8,666 shares were traded during trading, a decline of 53% from the average session volume of 18,409 shares. The stock had previously closed at $6.55. Finch Therapeutics Group […]